Genomic test may help identify prostate cancer patients at high risk of disease progression
After a biopsy comes back positive for prostate cancer, patients and their doctors are often left with a choice between […]
» Read moreHome »
Scientists at Urology Research Laboratory of the Department for BioMedical Research (DBMR), University of Bern and Urology Department of the […] Paruresis is an embarrassing condition which severely limits the quality of life of the person concerned. It is best defined […] For men with early-stage prostate cancer, choices about initial treatment carry varying risks of “financial toxicity,” reports a study in […] Prolonged androgen deprivation therapy (ADT) can impair cardiorespiratory fitness and increase risk of cardiovascular death in prostate cancer patients with […] Doctors are reporting success with newer drugs that control certain types of cancer better, reduce the risk it will come […] What molecular event happens for prostate cancer to progress faster and to be deadlier when patients eat a high-fat diet? […] Consuming lots of milk, cheese and butter may raise the risk of prostate cancer by up to 76%, reveals review […] Men who became fathers through assisted reproduction techniques seem to be at higher risk for prostate cancer and early onset […] Men who are diagnosed with low-risk prostate cancer usually opt for active surveillance—a monitoring of their cancer over time without […]
Researchers establish organoid culture models from prostate tumor biopsies
Paruresis – Shy Bladder Syndrome
Evaluating the ‘financial toxicity’ of prostate cancer treatment
Common prostate cancer treatment may impair cardiorespiratory fitness, raise risk of CV death
New drugs make headway against lung, prostate, colon cancers
High-fat diet proven to fuel prostate cancer progression by imitating a key cancer alteration
Consuming lots of milk and cheese may raise risk of prostate cancer
Fathering children by assisted reproduction linked to increased risk of prostate cancer
Stephenson Cancer Center testing drug for prostate cancer patients on active surveillance
